Filing metadata

Accession number
0001104659-21-147690
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Dec 08, 2021
Reporting period
Dec 06, 2021
Description
Insider transaction

Explore SEC Filings Hub